MTOR and acute lymphoblastic leukemia: In order to study the inhibition of Notch1 and PI3K/ AKT/mTOR signaling pathways simultaneously in T-ALL cell lines, a gamma secretase inhibitor called Compound E and a strong selective AKT inhibitor, AZD5363 were used.